Last updated on November 2019

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis


Brief description of study

The main objectives of this trial are to evaluate the long term efficacy and safety of different doses of BI 655064 versus placebo as add-on therapy to Standard of Care (SOC) during maintenance therapy for lupus nephritis.

Clinical Study Identifier: NCT03385564

Find a site near you

Start Over